|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.27 USD | +10.21% |
|
+3.14% | -12.94% |
| Apr. 30 | US FDA proposes curbs on mass compounding of Novo, Lilly's weight-loss drugs | RE |
| Apr. 29 | Wall Street's Wednesday Test Is Bigger Than Tech |  |
| Capitalization | 6.53B 5.55B 5.08B 4.79B 8.94B 617B 9.02B 60.25B 23.49B 296B 24.51B 23.99B 1,023B | P/E ratio 2026 * |
54.7x | P/E ratio 2027 * | 44.3x |
|---|---|---|---|---|---|
| Enterprise value | 7.33B 6.23B 5.7B 5.38B 10.04B 693B 10.13B 67.63B 26.36B 333B 27.51B 26.93B 1,148B | EV / Sales 2026 * |
2.7x | EV / Sales 2027 * | 2.3x |
| Free-Float |
91.04% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Hims & Hers Health, Inc.
| 1 day | +10.21% | ||
| 1 week | +3.14% | ||
| Current month | +4.05% | ||
| 1 month | +43.14% | ||
| 3 months | +46.25% | ||
| 6 months | -31.10% | ||
| Current year | -12.94% |
| 1 week | 25.35 |  | 28.52 |
| 1 month | 19.3 | | 31.86 |
| Current year | 13.74 | | 36.45 |
| 1 year | 13.74 | | 70.43 |
| 3 years | 5.65 | | 72.98 |
| 5 years | 2.72 | | 72.98 |
| 10 years | 2.72 | | 72.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Dudum
CEO | Chief Executive Officer | 37 | 2021-01-19 |
Oluyemi Okupe
DFI | Director of Finance/CFO | 40 | 2022-01-23 |
Mo Elshenawy
CTO | Chief Tech/Sci/R&D Officer | 52 | 2025-05-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Dudum
CHM | Chairman | 37 | 2021-01-19 |
Delos Cosgrove
BRD | Director/Board Member | 85 | 2021-01-19 |
David Wells
BRD | Director/Board Member | 54 | 2021-01-19 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.21% | +3.14% | -45.59% | +165.45% | 6.53B | |
| +4.17% | +12.23% | +1.97% | -71.08% | 1.31B | |
| -9.63% | -3.07% | - | - | 881M | |
| +0.19% | 0.00% | +71.85% | +510.59% | 867M | |
| +2.84% | +30.23% | +16.52% | -80.17% | 133M | |
| Average | +1.56% | +8.51% | +11.19% | +131.19% | 1.94B | |
| Weighted average by Cap. | +6.61% | +3.89% | -26.10% | +160.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.72B 2.31B 2.11B 1.99B 3.72B 257B 3.75B 25.07B 9.77B 123B 10.2B 9.98B 426B | 3.18B 2.7B 2.48B 2.34B 4.36B 301B 4.4B 29.36B 11.45B 144B 11.94B 11.69B 499B |
| Net income | 122M 103M 94.61M 89.3M 167M 11.49B 168M 1.12B 438M 5.52B 457M 447M 19.06B | 152M 129M 118M 111M 207M 14.31B 209M 1.4B 545M 6.87B 568M 556M 23.73B |
| Net Debt | 800M 680M 622M 587M 1.1B 75.6B 1.11B 7.38B 2.88B 36.31B 3B 2.94B 125B | 779M 662M 606M 572M 1.07B 73.55B 1.08B 7.18B 2.8B 35.33B 2.92B 2.86B 122B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-08 | 28.27 $ | +10.21% | 25,969,543 |
| 26-05-07 | 25.65 $ | -4.58% | 18,626,961 |
| 26-05-06 | 26.88 $ | +2.09% | 14,873,625 |
| 26-05-05 | 26.33 $ | -3.45% | 15,492,799 |
| 26-05-04 | 27.27 $ | -0.51% | 15,069,498 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HIMS Stock
Select your edition
All financial news and data tailored to specific country editions
